LeMaitre Vascular, Inc. LMAT
80.60 USD -0.66 (-0.81%)
At closeNov 3, 2026, 4:27 PM EST
80.60 0.00 0.00%
After hours · Nov 3, 4:27 PM ET
80.47 Day range 82.12
78.22 52-week range 118.01
- YTD
- -0.62%
- 1 year
- -7.27%
Analyst view
Consensus: buy
Buy
Price target (mean) 107.00 +32.8% upside
Now 80.60
- Target (low)
- 81.00
- Target (mean)
- 107.00
- Target (high)
- 132.00
Ratings (0m) 8 4 buy · 4 hold · 0 sell
- Strong buy2
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.68625 | 0.68 – 0.69 | 0.75 | -8.5% | 67.37M | +10.4% | 8 |
| Next quarter | 0.7775 | 0.77 – 0.79 | 0.68 | +14.3% | 72.24M | +12.1% | 8 |
| Current year | 2.88 | 2.84 – 2.90 | 2.52 | +14.2% | 276.53M | +10.8% | 8 |
| Next year | 3.18 | 3.04 – 3.30 | 2.88 | +10.4% | 302.95M | +9.6% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 3, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| May 6, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| May 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 6, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 26, 2026 | Roth Capital | Reiterated | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Feb 20, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Nov 7, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 15, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 23, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 6, 2025 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Aug 6, 2025 | Barrington Research | Upgrade | Market Perform | Outperform |
| Jul 22, 2025 | Barrington Research | Reiterated | Market Perform | Market Perform |
| Feb 28, 2025 | Lake Street | Maintained | Buy | Buy |
| Feb 28, 2025 | Citizens Capital Markets | Maintained | Buy | Buy |
| Feb 28, 2025 | Barrington Research | Downgrade | Outperform | Market Perform |
| Feb 13, 2025 | Wells Fargo | Initiated | — | Equal-Weight |
| Nov 1, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Nov 1, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 15, 2024 | Cantor Fitzgerald | Initiated | — | Neutral |
| Sep 20, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 20, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 2, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| May 3, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| May 3, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Apr 26, 2024 | Stifel | Upgrade | Hold | Buy |
| Feb 28, 2024 | Barrington Research | Maintained | Outperform | Outperform |